Gelsolin: a candidate for suppressor of human bladder cancer.
Human transitional cell carcinomas of the bladder frequently reveal chromosomal abnormalities that span a range between chromosome 9p12 and 9qter, even at early stages of bladder carcinogenesis. Because the gene that encodes an actin-regulatory protein, gelsolin, is localized in chromosome 9q33, we examined the expression of gelsolin in a number of human bladder cancer cell lines and tissues. In all 6 cell lines and in 14 of the 18 tumor tissues (77.8%), gelsolin expression was undetectable or extremely low in comparison with its expression in normal bladder epithelial cells. Furthermore, upon the introduction of the exogenous human or mouse authentic gelsolin cDNA into a human bladder cancer cell line, UMUC-2, gelsolin transfectants of UMUC-2 greatly reduced the colony-forming ability and the tumorigenicity in vivo. These results suggest that gelsolin plays a key role as a tumor suppressor in human urinary bladder carcinogenesis.
Tanaka
M
M
Laboratory of Molecular Genetics, Cancer Institute, Hokkaido University School of Medicine, Sapporo, Japan.
Müllauer
L
L
Ogiso
Y
Y
Fujita
H
H
Moriya
S
S
Furuuchi
K
K
Harabayashi
T
T
Shinohara
N
N
Koyanagi
T
T
Kuzumaki
N
N
D001483:Base Sequence; D015152:Blotting, Northern; D015153:Blotting, Western; D018260:Gelsolin / Q000378:metabolism* / Q000502:physiology; D005822:Genetic Vectors; D006801:Humans; D008969:Molecular Sequence Data; D014162:Transfection; D014407:Tumor Cells, Cultured; D014410:Tumor Stem Cell Assay; D001743:Urinary Bladder / Q000378:metabolism* / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000378:metabolism* / Q000473:pathology
D018260:Gelsolin